PSAT1通过p-AKT/SP1/ITGA2轴在雌激素受体阴性乳腺癌细胞中促进转移
Xingda Zhang1,2, Siyu Wang1,2, Wei Li1
1Department of Breast Surgery, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin 150081, China.
Biomolecules
|August 29, 2024
概括
脂氨酸脱酶1 (PSAT1) 通过激活p-AKT/SP1/ITGA2通路,促进ER阴性乳腺癌的转移. 这项研究揭示了PSAT1.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- PSAT1 (酸酶脱碳酶1) 显示了除了新陈代谢之外的月光功能,促进瘤恶性.
- 通过PSAT1驱动ER阴性乳腺癌细胞迁移的精确分子机制需要进一步阐明.
研究的目的:
- 研究PSAT1在促进ER阴性乳腺癌细胞迁移中的作用和分子机制.
- 确定关键的分子参与者和涉及PSAT1介导转移的途径.
主要方法:
- 对PSAT1和ITGA2.2进行基因表达分析 (qRT-PCR,免疫光,西部斑).
- 在体外和体外功能测试以评估细胞迁移.
- RNA测序 (RNA-seq) 用于识别差异表达的基因.
- 染色体免疫沉 (ChIP) 试验用于研究转录因子结合.
主要成果:
- 在ER阴性乳腺癌组织和细胞中,PSAT1的表达很高,与转移有积极的相关性.
- 通过p-AKT/SP1/ITGA2信号轴,PSAT1促进乳腺癌的转移.
- 在PSAT1上调节p-AKT,促进SP1核进入和随后的ITGA2转录,从而增强细胞迁移.
- ITGA2 枯竭或 p-AKT 抑制逆转了 PSAT1 诱导的细胞迁移.
结论:
- 这项研究阐明了PSAT1通过p-AKT/SP1/ITGA2途径促进ER阴性乳腺癌转移的机制.
- 这些发现提供了机制性见解,可以为减轻乳腺癌转移的治疗策略提供信息.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:20The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K